Skip to main content
. Author manuscript; available in PMC: 2021 Jul 9.
Published in final edited form as: Clin Pharmacol Ther. 2021 Feb 28;109(5):1197–1202. doi: 10.1002/cpt.2172

Figure 1: Overview of pharmacovigilance methods at varying stages of development.

Figure 1:

Established (green, left), emerging (yellow, middle), and experimental (red, right) pharmacovigilance data sources and systems are presented. Examples of methodological areas that are currently used and under active development for the analysis of these different data types are included in the bottom box.